Cellnovo
Latest round
- Series B
Last raised
- Feb 2011
Total raised
- $48M
Investors
- 8
About Cellnovo
Cellnovo, founded in 2002 in Swansea, UK, develops advanced diabetes management systems that integrate hardware and software solutions.63 each. Julian Shapley, the founder, has a history in technology ventures, further enhancing the company’s expertise.Cellnovo specializes in diabetes management solutions, offering a unique combination of connected insulin delivery devices and comprehensive digital health services. Their core product enables patients to manage their insulin delivery efficiently while tracking their glucose levels, thereby improving health outcomes.4 mn to expedite the development of new diabetes management products and enhance its existing services. The company is targeting expansion into additional European markets and aims to establish a stronger presence in North America by 2025, capitalizing on the rising demand for innovative diabetes solutions. Upcoming product launches are anticipated to bolster their market position and meet the growing needs of diabetic patients.
Who invested in Cellnovo
8 investors across 1 round
See all investors in Cellnovo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 4, 2011
Amount
$48M
Investors
Questions about Cellnovo
Who invested in Cellnovo?
Cellnovo has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellnovo raised?
Cellnovo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellnovo last raise money?
Cellnovo's most recent round on record is a Series B, in Feb 2011.
What does Cellnovo do?
Cellnovo, founded in 2002 in Swansea, UK, develops advanced diabetes management systems that integrate hardware and software solutions.
Where is Cellnovo headquartered?
Cellnovo is headquartered in Swansea, UK.
Which VCs invest in companies like Cellnovo?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Cellnovo's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Cellnovo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.